WUXIBiotechprnewswire

WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules

Sentiment:Positive (70)

Summary

WuXia293Stable platform demonstrates high titer, human glycosylation and improved product quality by eliminating or significantly alleviating truncation in difficult-to-express molecules. WuXia293Stable platform maintains stable expression and consistent product quality during long-term...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 11, 2025 by prnewswire

    WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules | WUXI Stock News | Candlesense